Jason Gerberry
Stock Analyst at Bank of America Securities
(4.91)
# 248
Out of 5,004 analysts
838
Total ratings
60.8%
Success rate
19.8%
Average return
Main Sectors:
Stocks Rated by Jason Gerberry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RPRX Royalty Pharma | Maintained: Buy | $63 | $57.65 | +9.28% | 10 | Sep 24, 2026 | |
| TLV: TEVA Teva Pharmaceutical Industries Limited | Reiterated: Buy | ILA 13,046 | ILA 12,060 | +8.17% | 1 | Sep 23, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $166 | $148.08 | +12.10% | 22 | Sep 23, 2026 | |
| ALKS Alkermes | Reiterated: Sell | $38 | $42.13 | -9.80% | 43 | Sep 21, 2026 | |
| XENE Xenon Pharmaceuticals | Reiterated: Buy | n/a | $36.56 | - | 17 | Sep 18, 2026 | |
| EXEL Exelixis | Reiterated: Sell | $41 | $56.73 | -27.73% | 37 | Sep 11, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $276 → $282 | $265.08 | +6.38% | 16 | Sep 8, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $93 → $91 | $43.93 | +107.15% | 49 | Sep 8, 2026 | |
| APMD Apnimed | Initiated Coverage: Buy | $41 | $22.49 | +82.30% | 1 | Aug 25, 2026 | |
| JAZZ Jazz Pharmaceuticals | Reiterated: Buy | $307 | $234.88 | +30.71% | 74 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $5.81 | +20.48% | 1 | Aug 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,344 | $1,150.99 | +16.77% | 19 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $39 | $30.61 | +27.43% | 5 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $86 | $62.21 | +38.24% | 16 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $31 → $7 | $3.76 | +86.17% | 13 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $79 → $92 | $67.49 | +36.32% | 20 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $49 | $26.89 | +82.22% | 3 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $276 | $193.45 | +42.67% | 30 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $0.4856 | +311.86% | 15 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $20 | $24.96 | -19.87% | 17 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $32 | $9.99 | +220.32% | 19 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $133 | $56.50 | +135.42% | 31 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $66.96 | +49.34% | 23 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $28 → $30 | $40.48 | -25.89% | 17 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $26 → $27 | $28.18 | -4.19% | 13 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $71 | $61.15 | +16.11% | 15 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $263 | $269.17 | -2.29% | 13 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $626 → $613 | $489.42 | +25.25% | 20 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $10 → $14 | $17.12 | -18.22% | 41 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $89 | $74.29 | +19.80% | 21 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $43 | $34.54 | +24.49% | 18 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $7.00 | $8.04 | -12.95% | 20 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $13.73 | - | 15 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $1 | $1.65 | -39.39% | 11 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $13.67 | -26.85% | 13 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $27.62 | - | 1 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $25 → $28 | $30.72 | -8.85% | 18 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $18.03 | -16.81% | 18 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.26 | n/a | 7 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.67 | n/a | 6 | Sep 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $4 → $3.5 | $1.32 | n/a | 7 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $4 → $2 | $7.20 | n/a | 10 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $5 → $1 | $0.7266 | n/a | 4 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $10.35 | n/a | 1 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $26 → $10 | $4.62 | n/a | 2 | Jul 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $27.85 | n/a | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $110 | $246.51 | n/a | 1 | Nov 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $6 | $0.0001 | n/a | 3 | Aug 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $132.95 | n/a | 2 | Jun 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $9 | $1.26 | n/a | 1 | Oct 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $18 | $3.48 | n/a | 7 | Nov 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $0.291 | n/a | 13 | Nov 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $59 → $37 | $24.63 | n/a | 7 | Nov 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $110 → $81 | $13.84 | n/a | 9 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $33 → $24 | $19.33 | n/a | 7 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $38.17 | n/a | 1 | Aug 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $14 | $4.27 | n/a | 9 | Aug 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $139.49 | n/a | 1 | Jul 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0007 | n/a | 3 | Jan 19, 2016 |
Royalty Pharma
Sep 24, 2026
Maintained: Buy
Price Target: $63
Current: $57.65
Upside: +9.28%
Teva Pharmaceutical Industries Limited
Sep 23, 2026
Reiterated: Buy
Price Target: ILA 13,046
Current: ILA 12,060
Upside: +8.17%
Merck & Co.
Sep 23, 2026
Reiterated: Buy
Price Target: $166
Current: $148.08
Upside: +12.10%
Alkermes
Sep 21, 2026
Reiterated: Sell
Price Target: $38
Current: $42.13
Upside: -9.80%
Xenon Pharmaceuticals
Sep 18, 2026
Reiterated: Buy
Price Target: n/a
Current: $36.56
Upside: -
Exelixis
Sep 11, 2026
Reiterated: Sell
Price Target: $41
Current: $56.73
Upside: -27.73%
AbbVie
Sep 8, 2026
Reiterated: Buy
Price Target: $276 → $282
Current: $265.08
Upside: +6.38%
Ionis Pharmaceuticals
Sep 8, 2026
Reiterated: Buy
Price Target: $93 → $91
Current: $43.93
Upside: +107.15%
Apnimed
Aug 25, 2026
Initiated Coverage: Buy
Price Target: $41
Current: $22.49
Upside: +82.30%
Jazz Pharmaceuticals
Aug 25, 2026
Reiterated: Buy
Price Target: $307
Current: $234.88
Upside: +30.71%
Aug 24, 2026
Initiated Coverage: Buy
Price Target: $7
Current: $5.81
Upside: +20.48%
Aug 21, 2026
Reiterated: Buy
Price Target: $1,344
Current: $1,150.99
Upside: +16.77%
Aug 18, 2026
Reiterated: Buy
Price Target: $30 → $39
Current: $30.61
Upside: +27.43%
Aug 18, 2026
Reiterated: Buy
Price Target: $86
Current: $62.21
Upside: +38.24%
Aug 12, 2026
Downgraded: Hold
Price Target: $31 → $7
Current: $3.76
Upside: +86.17%
Aug 12, 2026
Reiterated: Hold
Price Target: $79 → $92
Current: $67.49
Upside: +36.32%
Aug 12, 2026
Rated: Buy
Price Target: $49
Current: $26.89
Upside: +82.22%
Aug 10, 2026
Reiterated: Buy
Price Target: $276
Current: $193.45
Upside: +42.67%
Aug 10, 2026
Reiterated: Buy
Price Target: $2
Current: $0.4856
Upside: +311.86%
Aug 7, 2026
Reiterated: Sell
Price Target: $20
Current: $24.96
Upside: -19.87%
Aug 7, 2026
Reiterated: Buy
Price Target: $35 → $32
Current: $9.99
Upside: +220.32%
Aug 5, 2026
Reiterated: Buy
Price Target: $133
Current: $56.50
Upside: +135.42%
Aug 4, 2026
Reiterated: Buy
Price Target: $100
Current: $66.96
Upside: +49.34%
Aug 4, 2026
Reiterated: Sell
Price Target: $28 → $30
Current: $40.48
Upside: -25.89%
Aug 4, 2026
Reiterated: Hold
Price Target: $26 → $27
Current: $28.18
Upside: -4.19%
Aug 3, 2026
Reiterated: Buy
Price Target: $71
Current: $61.15
Upside: +16.11%
Jul 28, 2026
Reiterated: Hold
Price Target: $263
Current: $269.17
Upside: -2.29%
Jul 10, 2026
Reiterated: Hold
Price Target: $626 → $613
Current: $489.42
Upside: +25.25%
Jul 10, 2026
Reiterated: Sell
Price Target: $10 → $14
Current: $17.12
Upside: -18.22%
Jul 8, 2026
Reiterated: Buy
Price Target: $89
Current: $74.29
Upside: +19.80%
May 21, 2026
Reiterated: Buy
Price Target: $32 → $43
Current: $34.54
Upside: +24.49%
Feb 18, 2026
Reiterated: Sell
Price Target: $7.00
Current: $8.04
Upside: -12.95%
Feb 13, 2026
Reiterated: Sell
Price Target: n/a
Current: $13.73
Upside: -
Jan 12, 2026
Reiterated: Sell
Price Target: $1
Current: $1.65
Upside: -39.39%
Nov 10, 2025
Reiterated: Hold
Price Target: $10
Current: $13.67
Upside: -26.85%
Nov 7, 2025
Reiterated: Sell
Price Target: n/a
Current: $27.62
Upside: -
Nov 6, 2025
Reiterated: Sell
Price Target: $25 → $28
Current: $30.72
Upside: -8.85%
Nov 6, 2025
Reiterated: Buy
Price Target: $15
Current: $18.03
Upside: -16.81%
Oct 30, 2023
Rated: Hold
Price Target: n/a
Current: $1.26
Upside: n/a
Sep 28, 2023
Rated: Hold
Price Target: n/a
Current: $1.67
Upside: n/a
Aug 9, 2023
Reiterated: Sell
Price Target: $4 → $3.5
Current: $1.32
Upside: n/a
Aug 8, 2023
Downgraded: Sell
Price Target: $4 → $2
Current: $7.20
Upside: n/a
Jan 5, 2023
Reiterated: Sell
Price Target: $5 → $1
Current: $0.7266
Upside: n/a
May 17, 2022
Reiterated: Buy
Price Target: $11
Current: $10.35
Upside: n/a
Jul 15, 2020
Downgraded: Hold
Price Target: $26 → $10
Current: $4.62
Upside: n/a
Mar 11, 2020
Initiated Coverage: Buy
Price Target: $32
Current: $27.85
Upside: n/a
Nov 13, 2019
Initiated Coverage: Buy
Price Target: $110
Current: $246.51
Upside: n/a
Aug 20, 2019
Reiterated: Buy
Price Target: $5 → $6
Current: $0.0001
Upside: n/a
Jun 28, 2019
Downgraded: Sell
Price Target: n/a
Current: $132.95
Upside: n/a
Oct 16, 2018
Downgraded: Sell
Price Target: $9
Current: $1.26
Upside: n/a
Nov 20, 2016
Reiterated: Buy
Price Target: $14 → $18
Current: $3.48
Upside: n/a
Nov 15, 2016
Reiterated: Buy
Price Target: $34
Current: $0.291
Upside: n/a
Nov 2, 2016
Reiterated: Hold
Price Target: $59 → $37
Current: $24.63
Upside: n/a
Aug 10, 2016
Reiterated: Hold
Price Target: $110 → $81
Current: $13.84
Upside: n/a
Aug 9, 2016
Reiterated: Hold
Price Target: $33 → $24
Current: $19.33
Upside: n/a
Aug 8, 2016
Reiterated: Hold
Price Target: n/a
Current: $38.17
Upside: n/a
Aug 5, 2016
Reiterated: Hold
Price Target: $10 → $14
Current: $4.27
Upside: n/a
Jul 13, 2016
Reiterated: Buy
Price Target: $70
Current: $139.49
Upside: n/a
Jan 19, 2016
Downgraded: Hold
Price Target: n/a
Current: $0.0007
Upside: n/a